MARKET

BDTX

BDTX

Black Diamond Therapeutics, Inc.
NASDAQ
2.590
-0.080
-3.00%
After Hours: 2.640 +0.05 +1.93% 19:33 12/26 EST
OPEN
2.650
PREV CLOSE
2.670
HIGH
2.659
LOW
2.535
VOLUME
838.62K
TURNOVER
--
52 WEEK HIGH
4.940
52 WEEK LOW
1.195
MARKET CAP
147.57M
P/E (TTM)
7.14
1D
5D
1M
3M
1Y
5Y
1D
3 Low P/E Ratio Stocks Poised to Surge Over 100% in 2026
TipRanks · 4d ago
Weekly Report: what happened at BDTX last week (1215-1219)?
Weekly Report · 5d ago
Weekly Report: what happened at BDTX last week (1208-1212)?
Weekly Report · 12/15 09:32
Weekly Report: what happened at BDTX last week (1201-1205)?
Weekly Report · 12/08 09:32
Can Black Diamond Therapeutics’ (BDTX) Silevertinib CNS Data Redefine Its Precision Oncology Strategy?
Simply Wall St · 12/05 19:25
This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Benzinga · 12/04 14:30
Black Diamond Theraptcs Cut to Neutral From Buy by Guggenheim
Dow Jones · 12/04 13:58
Guggenheim Downgrades Black Diamond Therapeutic to Neutral
Benzinga · 12/04 13:48
More
About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The Company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat central nervous system disease. The Company is advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. Its BDTX-4933 pipeline product is out-licensed to Servier. BDTX-4933 is designed to target RAS and RAF alterations in solid tumors. It is exploring partnership opportunities for its FGFR2/3 selective development candidate BDTX-4876.

Webull offers Black Diamond Therapeutics Inc stock information, including NASDAQ: BDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDTX stock methods without spending real money on the virtual paper trading platform.